Elevance Health, Inc. (ELV) reported third-quarter 2024 adjusted earnings per share (EPS) of $8.37, which lagged the Zacks Consensus Estimate by 13.7$44.7 billion rose 5.2% year over year. Moreover, the top line beat the consensus mark by 3.4%.Quarterly earnings were impacted by rising expenses and a decline in Medicaid and Medicare membership. However, improved product revenues in the CarelonRx business and better premiums in the Hea ...